Riskpilot← Back to searchSign inGet full accessSELAND OPTIKK JÆREN AS
ASActiveOrg 974271311Jærvegen 549, 4350 KleppeRetail sale of medical and orthopaedic goods · NACE 4774Est. 19955 employees
Revenue 2024
NOK 3M
+2% vs 2023
EBITDA margin
-2.6%
+63% vs 2023
Equity ratio
16.0%
Financial strength
Net profit 2024
NOK -63K
+63% vs 2023
| Revenue | NOK 3M | +2% |
| EBITDA | NOK -77K | +63% |
| Net profit | NOK -63K | +63% |
| Total assets | NOK 1,2M | -3% |
| Equity | NOK 192K | +11% |
| Employees | 5 | — |
Legal name
SELAND OPTIKK JÆREN AS
Org number
974271311
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
13. februar 1995
Share capital
—
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Jærvegen 549, 4350 Kleppe
Phone
+4751420390
Email
klepp@selandoptikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 183 | 3 148 | 2 713 | 2 958 | 3 004 |
| Staff expenses | −1 366 | −1 110 | −1 147 | −1 312 | −1 458 |
| EBITDA | 245 | 292 | −91 | −206 | −77 |
| Depreciation & amort. | −62 | −46 | −42 | −11 | −4 |
| EBIT | 183 | 246 | −133 | −217 | −81 |
| Net financials | −8 | −9 | −11 | 0 | 1 |
| Profit before tax | 175 | 237 | −143 | −217 | −81 |
| Tax | 38 | 52 | −32 | −48 | −18 |
| Net profit | 136 | 185 | −112 | −169 | −63 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 136 | 1 368 | 1 018 | 1 236 | 1 197 |
| Equity | 123 | 139 | 27 | 173 | 192 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 013 | 1 229 | 991 | 1 063 | 1 005 |
| Total debt | 1 013 | 1 229 | 991 | 1 063 | 1 005 |
EBITDA margin
-2.6%
This company
15.8%
Market median
-116% vs market
20202024
Equity ratio
16.0%
This company
38.2%
Market median
-58% vs market
20202024
Return on equity
-32.9%
This company
18.4%
Market median
-279% vs market
20202024
Net profit margin
-2.1%
This company
8.1%
Market median
-126% vs market
20202024
Asset turnover
2.51×
This company
1.12×
Market median
+124% vs market
20202024
Debt / equity
5.25×
This company
0.62×
Market median
-747% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
FG Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (2) | ||
MR Deputy Member | Deputy Member | 2012 – 2023 |
OA Chief Executive Officer | Chief Executive Officer | 2013 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Board of Directors | 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tm - Holding As
SELAND OPTIKK JÆREN AS Board members of SELAND OPTIKK JÆREN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Magne Roar Seland | Deputy Member | 0 companies |
| Frida Granum Aase | Chief Executive Officer | 0 companies |
| Ole Andre Endresen | Chief Executive Officer | 0 companies |
| Thor Magne Seland | Chairman | 0 companies |
| Jens Kryger | Board of Directors | 0 companies |